WST West Pharmaceutical Services, I
Healthcare · Medical Instruments & Supplies
328.20
-7.67%
Informazioni sull'azienda
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Intervallo 52 settimane
Analisi approfondita del dividendo
West Pharmaceutical Services, I (WST) operates in the Medical Instruments & Supplies sector. The company currently offers a dividend yield of 0.26%. This yield is within its 5-year historical range of 0.18% to 0.33%, with a 5-year average of 0.24%. Yield Theory suggests the stock is currently valued "fairly." No momentum, value, or overall rating scores are provided in the data.
Storico dei dividendi
West Pharmaceutical Services, I has maintained a 28-year dividend increase streak, earning it a "Champion" tier classification. The dividend has grown with a 3-year compound annual growth rate (CAGR) of 5.27% and a 5-year CAGR of 5.59%. At this rate, the dividend would double in approximately 12.9 years. Annual dividends per share have been: 0.40 USD (2014), 0.44 USD (2015), 0.48 USD (2016), 0.52 USD (2017), 0.56 USD (2018), 0.60 USD (2019), 0.64 USD (2020), 0.68 USD (2021), 0.72 USD (2022), 0.76 USD (2023), 0.80 USD (2024), and 0.84 USD (2025).
Quantic · Gratis
Sblocca l'analisi completa
Analisi della sicurezza del dividendo, i rischi chiave e cosa monitorare.
Generato dall'IA dai dati sui dividendi di Quantic · Aggiornato il 24 Jul 2026 · Informazioni, non consulenza finanziaria.
Mostrato in inglese — una traduzione è in arrivo.
Storico prezzi
Profilo del dividendo
Fascia di rendimento Il rendimento da dividendo attuale di un'azione confrontato con il suo stesso intervallo degli ultimi cinque anni — minimo, media e massimo. Vicino al massimo le azioni appaiono relativamente economiche per il reddito che pagano; vicino al minimo, relativamente care. È l'immagine dietro la Dividend Yield Theory. Scopri di più → (5 anni)
Calendario dei pagamenti
Storico dei dividendi
Dividendo per azione per anno
Debito e leva finanziaria
Ultimi dati di bilancio pubblicati.
seguita da 1
Compare in questi elenchi
WST soddisfa i criteri di queste classifiche di dividendi.
Nuovo negli investimenti in dividendi?
Informazioni, non consulenza finanziaria.
Quantic · Gratis
Monitora WST e tutto il tuo portafoglio
Rendimento reale, sicurezza del dividendo, reddito netto d'imposta e il tuo percorso verso la libertà — gratis, senza connessione al broker.